Provectus Biopharmaceuticals (PVCT) Stock Chart & Stock Price History $0.10 +0.00 (+0.41%) As of 04/23/2025 09:32 AM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock Provectus Biopharmaceuticals Stock Price Performance 5 Day Performance+2.17%1 Month Performance+1.43%3 Month Performance-14.95%6 Month Performance-7.91%Year-To-Date Performance-17.57%1 Year Performance-48.97% Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address PVCT Stock Chart for Thursday, April, 24, 2025 PVCT Chart by TradingView Provectus Biopharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2025$0.10$0.10+2.91%$0.10$0.1050,000 shs$41.61 million04/22/2025$0.09$0.10+4.23%$0.10$0.0918,577 shs$40.43 million04/21/2025$0.10$0.09-4.75%$0.10$0.09216,450 shs$38.79 million04/18/2025$0.10$0.10$0.10$0.0957,070 shs$40.73 million04/17/2025$0.10$0.10-0.72%$0.10$0.0957,070 shs$40.73 million04/16/2025$0.10$0.10-0.91%$0.10$0.09110,200 shs$41.02 million04/15/2025$0.10$0.10+3.68%$0.10$0.105,100 shs$41.40 million04/14/2025$0.10$0.10-4.04%$0.10$0.09329,407 shs$39.93 million04/11/2025$0.10$0.10+3.02%$0.10$0.1031,218 shs$41.61 million04/10/2025$0.10$0.10-2.93%$0.10$0.09160,166 shs$40.39 million Get the Latest News and Ratings for PVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/09/2025$0.10$0.10+1.23%$0.10$0.10106,000 shs$41.61 million04/09/2025$0.10$0.10+1.23%$0.10$0.10106,000 shs$41.61 million04/08/2025$0.10$0.10-1.61%$0.10$0.10330,734 shs$41.10 million04/08/2025$0.10$0.10-1.61%$0.10$0.10330,734 shs$41.10 million04/07/2025$0.10$0.10+2.26%$0.10$0.0961,396 shs$41.78 million04/04/2025$0.10$0.10+0.52%$0.10$0.09397,895 shs$40.85 million04/03/2025$0.10$0.10-3.01%$0.10$0.09352,144 shs$40.64 million04/02/2025$0.10$0.10-0.20%$0.10$0.0916,698 shs$41.90 million04/01/2025$0.10$0.10-0.10%$0.10$0.0999,390 shs$41.99 million03/31/2025$0.10$0.10-0.20%$0.10$0.1091,283 shs$42.03 million03/28/2025$0.10$0.10+0.20%$0.10$0.10325,757 shs$42.11 million03/27/2025$0.09$0.10+9.05%$0.10$0.09160,001 shs$42.03 million03/26/2025$0.10$0.09-8.12%$0.10$0.0924,873 shs$38.54 million03/25/2025$0.10$0.10+2.25%$0.10$0.09207,396 shs$41.94 million03/24/2025$0.11$0.10-8.01%$0.11$0.101.67 million shs$41.02 million Related Companies CYBN Stock Price Chart IPHA Stock Price Chart NGNE Stock Price Chart FULC Stock Price Chart PRME Stock Price Chart ANNX Stock Price Chart MOLN Stock Price Chart NBTX Stock Price Chart ACTU Stock Price Chart RZLT Stock Price Chart Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PVCT) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provectus Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Provectus Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
